Table 1.
Ultrastaging of sentinel lymph node using H&E and IHC in patients with cervical cancer
| Study | Year | Method of analysis | Nb of patients | FIGO stage | Macrometastatic SLN (%) | Micrometastatic SLN (%) |
|---|---|---|---|---|---|---|
| Lambaudie | 2003 | H&E +IHC | 12 | IA2-IB1 | 2 (18.2) | 0 |
| Niikura | 2004 | H&E +IHC | 20 | IB1-IIA | 2 (10) | 0 |
| Martinez Palones | 2004 | H&E +IHC | 23 | IA2-IIA | 3 (13) | 0 |
| Kraft | 2006 | H&E +IHC | 54 | IB1-III | 21 (42) | na |
| Total | 109 | 28 (25.7) | ||||
SLN: sentinel lymph node; H&E: hematein eosin staining; IHC: immunohistochemy; SS: serial sectioning; HPV: human papilloma virus; na: not available